List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 38 studies with search of: hypersomnia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed
Has Results 		Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD
Conditions: Excessive Sleepiness;   Shift Work Sleep Disorder
Interventions: Drug: Armodafinil 150 mg/day;   Drug: Placebo
2 Completed
Has Results 		Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Armodafinil;   Drug: Placebo
3 Completed Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder
Condition: Excessive Sleepiness
Interventions: Drug: armodafinil;   Drug: placebo
4 Completed CEP-10953 in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
Conditions: Sleep Apnea, Obstructive;   Sleep Apnea Syndromes
Intervention: Drug: CEP-10953
5 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Modafinil
6 Completed Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Adults With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome With Comorbid Major Depressive Disorder or Dysthymic Disorder
Conditions: Sleep Disorders;   Obstructive Sleep Apnea;   Major Depressive Disorder;   Dysthymic Disorder
Interventions: Drug: armodafinil;   Drug: placebo
7 Completed
Has Results 		Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
Conditions: Obstructive Sleep Apnea;   Sleep Hypopnea
Interventions: Drug: Armodafinil 150 mg/day;   Drug: Placebo
8 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome
Condition: Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
9 Completed PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Narcolepsy;   Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
10 Completed VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
Condition: Excessive Somnolence
Intervention: Drug: VSF-173
11 Completed Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy
Intervention: Drug: PROVIGIL (modafinil)
12 Completed Extension Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy
Intervention: Drug: CEP-10953
13 Recruiting Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
Condition: Traumatic Brain Injury
Intervention: Drug: Armodafinil
14 Recruiting Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
Condition: Traumatic Brain Injury
Interventions: Drug: Armodafinil;   Other: Placebo
15 Recruiting Sleep Disorders of Patients With Diseases of the Nervous System
Conditions: Hypersomnia;   Narcolepsy;   Nervous System Disease;   Sleep Disorder
Intervention:
16 Completed CEP-10953 for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions: Narcolepsy;   Sleep Apnea, Obstructive;   Sleep Apnea Syndromes;   Shift-Work Sleep Disorder
Intervention: Drug: CEP-10953
17 Completed Study to Evaluate the Effects of Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance in Adults With OSAHS Who Use nCPAP Therapy
Condition: Excessive Sleepiness
Interventions: Drug: Armodafinil;   Drug: Placebo
18 Completed Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Excessive Day Time Sleepiness;   Narcolepsy
Intervention: Drug: Armodafinil
19 Suspended Light Exposure to Treat Sleep Disruption in Older People
Conditions: Sleep Initiation and Maintenance Disorders;   Circadian Rhythm Sleep Disorders;   Hypersomnia
Intervention: Procedure: light exposure
20 Not yet recruiting Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
Conditions: Narcolepsy;   Hypersomnia
Interventions: Drug: Modafinil;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-38)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services